VTAK Stock Alert: Why Atlantic Trading Called Catheter Precision During 85% Intraday Surge

VTAK (Catheter Precision, Inc.) was a micro-cap, low-float name that exploded onto the radar on July 7, 2026. The stock opened at $1.21, ripped to an intraday high of $1.74, and had surged over 85% from its previous close of $0.71, the kind of violent, low-float move that demands attention.

The catalyst was a combination of news indicators, including Flyte, Catheter Precision’s technology-enabled Regional Air Mobility subsidiary.

Flyte announced a strategic partnership with LifeVac, equipping its entire fleet of Cirrus Vision Jets with FDA-authorised airway clearance devices (an announcement that reinforced Flyte’s safety-first brand positioning and added to its growing profile as a differentiated player in regional private aviation). On the same day, news that Flyte had cleared over $1 million in revenue and surpassed 1,000 active users in the first half of 2026 gave the story real operational credibility, showing this was more than a concept, but a revenue-generating business scaling in real time.

A separate $2.2 million strategic investment announcement added further fuel, signalling outside confidence in the platform.

For a micro-cap float, that combination of a partnership announcement, a revenue milestone, and fresh investment news landing on the same day was more than enough to ignite the kind of retail-driven price action that followed.

After the open, VTAK didn’t cool off, it kept pushing higher with volatility picking up through the session. The price action was strong and directional, and the team monitored it closely as momentum built. We waited for our setup to fully confirm before making the call.

Once the setup confirmed, Arlette announced the opportunity to the Atlantic Trading community, alerting members to the move in real time.